Extended storage of platelet-rich plasma-prepared platelet concentrates in plasma or Plasmalyte.
BACKGROUND
Using bacterial detection or pathogen reduction, extended platelet (PLT) storage may be licensed if PLT viability is maintained. The Food and Drug Administration (FDA)'s poststorage PLT acceptance guidelines are that autologous stored PLT recoveries and survivals should be 66 and 58% or greater, respectively, of each donor's fresh PLT data.


METHODS
Nonleukoreduced PLT concentrates were prepared from whole blood donations. Autologous PLT concentrates from 62 subjects were stored in 100% plasma (n=44) or 20% plasma/80% Plasmalyte (n=18), an acetate-based, non-glucose-containing crystalloid solution previously used for PLT storage. Fresh PLTs were obtained on the day the donor's stored PLTs were to be transfused. The fresh and stored PLTs were alternately radiolabeled with either (51) chromium or (111) indium, and in vitro measurements were performed on the stored PLTs.


RESULTS
The FDA's PLT recovery criteria were met for 7 days of plasma storage, but PLT survivals maintained viability for only 6 days. Plasmalyte-stored PLTs did not meet either acceptance criteria after 6 days of storage. After 7 days of storage, PLT recoveries averaged 43±4 and 30±4% and survivals 4.1±0.4 and 2.0±0.2 days for plasma- and Plasmalyte-stored PLTs, respectively (p=0.03 for recoveries and p<0.001 for survivals). Poststorage PLT recoveries correlated with the commonly used in vitro PLT quality measurements of hypotonic shock response and annexin V binding, while survivals correlated with extent of shape change, morphology score, and pH.


CONCLUSIONS
There is a progressive decrease in recoveries and survivals of plasma-stored PLTs over time. PLT viability is better maintained in plasma than Plasmalyte.
Slichter
Sherrill J
SJ
Puget Sound Blood Center and the University of Washington School of Medicine, Seattle, Washington 98104-1256, USA. sjslichter@psbc.org
Bolgiano
Doug
D
Corson
Jill
J
Jones
Mary Kay
MK
Christoffel
Todd
T
D001792:Blood Platelets / Q000166:cytology* / Q000378:metabolism*; D001793:Blood Preservation / Q000379:methods*; D002470:Cell Survival / Q000502:physiology; D006801:Humans; D053657:Platelet-Rich Plasma; D013997:Time Factors
Transfusion. 1986 Jan-Feb;26(1):30-6
3511573
Transfusion. 1997 Apr;37(4):423-35
9111281
Transfus Med Rev. 2006 Apr;20(2):158-64
16565028
Curr Opin Hematol. 2006 Sep;13(5):323-30
16888436
Transfusion. 1975 Sep-Oct;15(5):414-21
823
Transfus Med Rev. 1999 Jul;13(3):153-63
10425688
Hematology Am Soc Hematol Educ Program. 2003;:575-89
14633800
Transfusion. 2009 May;49(5):903-12
19170988
Blood. 2003 Mar 15;101(6):2426-33
12456508
Transfusion. 2004 Jan;44(1):36-41
14692965
Transfusion. 2004 Apr;44(4):618-9; author reply 619
15043581
Vox Sang. 2000;78 Suppl 2:211-5
10938955
Transfusion. 1984 Mar-Apr;24(2):147-52
6710588
Transfusion. 1985 Nov-Dec;25(6):551-6
4071600
Transfusion. 2003 Jan;43(1):2-6
12519424
Blood. 1986 Mar;67(3):672-5
3947742
Blood. 2004 Sep 1;104(5):1534-41
15138160
J Trauma. 2006 Jun;60(6 Suppl):S78-82
16763485
Transfus Med. 2003 Aug;13(4):173-87
12880388
Transfusion. 1998 Jan;38(1):31-40
9482391
Transfusion. 2003 Sep;43(9):1276-85
12919431
Transfusion. 2001 Apr;41(4):477-82
11316897
Vox Sang. 2004 Apr;86(3):183-8
15078253
Blood. 2005 May 15;105(10):4106-14
15692069
Vox Sang. 2013 May;104(4):324-30
23384253
Comput Biol Med. 1988;18(4):305-15
3409677
Transfusion. 2002 Jul;42(7):847-54
12375656
Blood. 1985 Nov;66(5):1105-9
4052629
Transfusion. 1991 Jan;31(1):21-5
1824731
Transfusion. 1994 Sep;34(9):750-5
7522362
Transfus Med. 2000 Dec;10(4):257-64
11123809
Transfusion. 2004 Jan;44(1):131-3
14692979
Br J Haematol. 1997 Jun;97(4):908-16
9217196
Transfusion. 2005 Aug;45(8):1356-61
16078926